Keywords: ضد انعقاد یا ضدپلاکت; Venous thromboembolism; Anticoagulant; Antiplatelet; Deep vein thrombosis; Pulmonary embolism;
مقالات ISI ضد انعقاد یا ضدپلاکت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد انعقاد یا ضدپلاکت; anticoagulant; antiplatelet; apixaban; blood thinners; dabigatran; dermatologic surgery; dietary supplements; prasugrel; rivaroxaban; ticagrelorADP, adenosine diphosphate; AF, atrial fibrillation; CVA, cerebrovascular accident; FDA, Food and Drug Administ
Keywords: ضد انعقاد یا ضدپلاکت; Protein tyrosine phosphatases; PTP; Inhibitor; Thrombosis; Antithrombotic; Platelets; Antiplatelet; Therapy; Drug; GPVI; CLEC-2; DUSP3; VHR; CD148; PTP1B; SHP1; SHP2;
Keywords: ضد انعقاد یا ضدپلاکت; Anticoagulation; Antiplatelet; Intracranial hemorrhage; Coagulopathy
Keywords: ضد انعقاد یا ضدپلاکت; Aneurysm; Antiplatelet; Aspirin; Hemorrhage; Natural history; Outcome; Rupture; CI; Confidence interval; HH; Hunt and Hess; ISUIA; International Study of Unruptured Intracranial Aneurysms; OR; Odds ratio; SAH; Subarachnoid hemorrhage;
Keywords: ضد انعقاد یا ضدپلاکت; Antiplatelet; Anticoagulant; Venous thromboembolism
Keywords: ضد انعقاد یا ضدپلاکت; Antiplatelet; ischemic stroke; aspirin; clopidogrel;
Keywords: ضد انعقاد یا ضدپلاکت; acute coronary syndrome; antiplatelet; clopidogrel;
Keywords: ضد انعقاد یا ضدپلاکت; Antiplatelet; Anticoagulation; Bleeding; Thrombosis; Novel oral anticoagulants
Keywords: ضد انعقاد یا ضدپلاکت; Intracerebral hemorrhage; antiplatelet; anticoagulant; clinical outcome;
Keywords: ضد انعقاد یا ضدپلاکت; Natural bioactive compounds; Functional foods; Antiplatelet; Multiple targets;
Keywords: ضد انعقاد یا ضدپلاکت; Anticoagulation; Antiplatelet; Warfarin; Clopidogrel; Aspirin;
Keywords: ضد انعقاد یا ضدپلاکت; Carotid artery stenosis; stenting; antiplatelet; adverse event;
Keywords: ضد انعقاد یا ضدپلاکت; anticoagulant; antiplatelet; heart failureACE, angiotensin-converting enzyme; ACS, acute coronary syndromes; ADP, adenosine diphoshpate; AF, atrial fibrillation; CAD, coronary artery disease; CI, confidence interval; F, circulating coagulation factor; GP,
Keywords: ضد انعقاد یا ضدپلاکت; Anticoagulant; Antiplatelet; Periprocedural; Atrial fibrillation; CHA2DS2-VASc;
Keywords: ضد انعقاد یا ضدپلاکت; Unstable angina; Non-ST elevation MI; Acute coronary syndromes; Management; Revascularization; Antiplatelet; Antithrombotic;
Keywords: ضد انعقاد یا ضدپلاکت; Thrombosis; Antiplatelet; Pyroglutamic acid; Aminomethylpiperidine; Collagen; Epinephrine;
Keywords: ضد انعقاد یا ضدپلاکت; Antiplatelet; Anticoagulant; Hematoma;
Keywords: ضد انعقاد یا ضدپلاکت; Acute stroke; clopidogrel; loading; antiplatelet; hemorrhage;
Keywords: ضد انعقاد یا ضدپلاکت; Pyrazole; Carboxamide; Antiplatelet; Arachidonic acid;
Keywords: ضد انعقاد یا ضدپلاکت; antiplatelet; stroke prevention; bleeding; mixed treatment comparison; aspirin; dipyridamole;
Keywords: ضد انعقاد یا ضدپلاکت; Ischemic stroke; thromboembolism; antithrombotic; anticoagulant; antiplatelet; withdrawal; discontinuation; survey
Comparison of different microscopy approaches to quantification of inhibitory effect on thrombus formation under flow conditions by the example of adenosine receptor agonist HE-NECA
Keywords: ضد انعقاد یا ضدپلاکت; Antiplatelet; Flow chamber; Image analysis; Flow methods; Thrombus formation; HE-NECA; 2-hexynyl-5â²-ethylcarboxamidoadenosine;
Manejo perioperatorio y periprocedimiento del tratamiento antitrombótico: documento de consenso de SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT y AEU
Keywords: ضد انعقاد یا ضدپلاکت; Antitrombótico; Anticoagulación; Antiagregación; CirugÃa; Antithrombotic; Anticoagulation; Antiplatelet; Surgery; ACOD; anticoagulante oral de acción directa; AVK; antagonista de la vitamina K; DAP; doble antiagregación plaquetaria; FA; fibrilación
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Keywords: ضد انعقاد یا ضدپلاکت; Antithrombotic; Anticoagulation; Antiplatelet; Surgery; Antitrombótico; Anticoagulación; Antiagregación; CirugÃa; AF; atrial fibrillation; DAPT; dual antiplatelet therapy; DES; drug-eluting stent; DOAC; direct oral anticoagulant; PCI; percutaneous cor
NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis
Keywords: ضد انعقاد یا ضدپلاکت; Platelet; Antiplatelet; Oxidative stress; NADPH oxidase; NOX2;
Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer
Keywords: ضد انعقاد یا ضدپلاکت; Antiplatelet; Drug; Esophagus; Risk Factor; Stomach; BMI; body mass index; CPRD; UK Clinical Practice Research Datalink; HR; hazard ratio; ICD; International Classification of Diseases; MICE; multiple imputation with chained equations; NCDR; National Can
The N-terminal-truncated recombinant fibrin(ogen)olytic serine protease improves its functional property, demonstrates in vivo anticoagulant and plasma defibrinogenation activity as well as pre-clinical safety in rodent model
Keywords: ضد انعقاد یا ضدپلاکت; Fibrinogen degradation; Anticoagulant; Cell cycle; Antiplatelet;
Antithrombotic Management After Transcatheter Aortic Valve Replacement
Keywords: ضد انعقاد یا ضدپلاکت; antiplatelet; antithrombotic; leaflet thrombosis; stroke; TAVR;
Original articleMetabolomic and elemental analysis of camel and bovine urine by GC-MS and ICP-MS
Keywords: ضد انعقاد یا ضدپلاکت; Camel urine; Metabolomics; GC-MS; ICP-MS; Anticancer; Antiplatelet;
Major determinants for the selecting antithrombotic therapies in patients with nonvalvular atrial fibrillation in Japan (JAPAF study)
Keywords: ضد انعقاد یا ضدپلاکت; Antiplatelet; Cross-sectional study; Nonvalvular atrial fibrillation; Oral anticoagulant;
Retrospective Cohort Study Examining Reduced Intensity and Duration of Anticoagulant and Antiplatelet Therapy Following Left Atrial Appendage Occlusion with the WATCHMAN Device
Keywords: ضد انعقاد یا ضدپلاکت; WATCHMAN; Left atrial appendage occlusion; Anticoagulation; Antiplatelet; Stroke; Atrial fibrillation;
Synthesis and pharmacological activity of diorganoantimony(III) and triorganoantimony(V) derivatives of Schiff bases derived from amino acids
Keywords: ضد انعقاد یا ضدپلاکت; Diorganoantimony(III); Triorganoantimony(V); Bifunctional bidentate; Antioxidant; Antimicrobial; Antiplatelet;
Review ArticleFlow diversion with the pipeline embolization device for patients with intracranial aneurysms and antiplatelet therapy: A systematic literature review
Keywords: ضد انعقاد یا ضدپلاکت; APT; antiplatelet; ASA; aspirin; PED; Pipeline Embolization Device; Antiplatelet therapy; Aspirin; Intracranial aneurysms; Flow diverter; Pipeline embolization device;
Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin
Keywords: ضد انعقاد یا ضدپلاکت; Acid-Suppressive Drugs; Hemorrhage; ASA; Antiplatelet; CI; confidence interval; GI; gastrointestinal; H2RA; H2-receptor antagonists; PPI; proton pump inhibitor;
Pleiotropic effects of ticagrelor: Myth or reality?
Keywords: ضد انعقاد یا ضدپلاکت; Antiplatelet; Acute coronary syndrome; Adenosine plasma; P2Y12 adenosine diphosphate receptor blocker; Traitement anti-agrégant plaquettaire; Syndrome coronaire aigu; Adénosine plasmatique; Antogoniste des récepteurs P2Y12; ACS; acute coronary syndrome
Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome
Keywords: ضد انعقاد یا ضدپلاکت; antiplatelet; clopidogrel; cost-effectiveness; prasugrel; ticagrelor;
Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling
Keywords: ضد انعقاد یا ضدپلاکت; LL-37; Antiplatelet; Antithrombosis; Src/PI3K/Akt signalingAMP, antimicrobial peptide; ADP, adenosine diphosphate; TxA2, thromboxane A2; GPIIb/IIIa, glycoprotein IIb–IIIa; MAPK, mitogen activated protein kinase; PI3K, phosphatidylinositol 3-kinase; SD, Sp
Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling
Keywords: ضد انعقاد یا ضدپلاکت; Ferulic acid; Antithrombotic; Antiplatelet; Coagulation
Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation
Keywords: ضد انعقاد یا ضدپلاکت; anticoagulation; antiplatelet; atriopulmonary; thromboembolism; APC; atriopulmonary connection; CI; confidence interval; CT; computed tomography; HR; hazard ratio; INR; international normalized ratio; TEC; thrombotic and embolic complication; TTE; transth
Amides and neolignans from the aerial parts of Piper bonii
Keywords: ضد انعقاد یا ضدپلاکت; Piper bonii; Piperaceae; Amides; Neolignans; Antiplatelet;
Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines
Keywords: ضد انعقاد یا ضدپلاکت; acute coronary syndrome; anticoagulants; antiplatelet; quality of care; risk assessment; ACS; acute coronary syndromes; COR; Class of Recommendation; DAPT; dual antiplatelet therapy; GPI; glycoprotein IIb/IIIa receptor inhibitor; GWC; guideline writing co
Pharmacogenetics in Oral Antithrombotic Therapy
Keywords: ضد انعقاد یا ضدپلاکت; Pharmacogenetics; Pharmacogenomics; Antithrombotic; Antiplatelet; Anticoagulant; Personalized medicine;
Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study
Keywords: ضد انعقاد یا ضدپلاکت; Atrial fibrillation; Traffic accident; Trauma; Antiplatelet; Anticoagulant; CHA2DS2-VASc
Ayadualin, a novel RGD peptide with dual antihemostatic activities from the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis
Keywords: ضد انعقاد یا ضدپلاکت; RDG peptide; Sand fly; Saliva; Anticoagulant; Antiplatelet
Purified polysaccharides of Geoffroea spinosa barks have anticoagulant and antithrombotic activities devoid of hemorrhagic risks
Keywords: ضد انعقاد یا ضدپلاکت; Polysaccharides; Geoffroea spinosa; Structure; Anticoagulant; Antithrombotic; Antiplatelet; aPTT; activated partial thromboplastin time; PT; prothrombin time; ADP; adenosine diphosphate; TPL; total polysaccharides; BSA; bovine serum albumin; PRP; platelet
Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study
Keywords: ضد انعقاد یا ضدپلاکت; Atrial fibrillation; Fracture; Osteoporosis; Antiplatelet; Anticoagulant; CHA2DS2-VASc;
Neurologic Events After Transcatheter Aortic Valve Replacement
Keywords: ضد انعقاد یا ضدپلاکت; TAVR; Transcatheter aortic valve replacement; Stroke; Embolic protection device; Antiplatelet; Anticoagulation;
Antiplatelet and antithrombotic activity of a fibrin(ogen)olytic protease from Bacillus cereus strain FF01
Keywords: ضد انعقاد یا ضدپلاکت; Anticoagulant; Antiplatelet; Thrombolytic agent;
Resveratrol inhibits collagen-induced platelet stimulation through suppressing NADPH oxidase and oxidative inactivation of SH2 domain-containing protein tyrosine phosphatase-2
Keywords: ضد انعقاد یا ضدپلاکت; Resveratrol; Antiplatelet; Reactive oxygen species; NADPH oxidase; SH-2 domain-containing protein tyrosine phosphatase;